LICENSING AND COLLABORATION ARRANGEMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Breakdown of licensing and collaboration revenue

The breakdown of licensing and collaboration revenue was as follows:

	Year Ended December 31,
	2023		2022
Recognition in the year	$	632	$	1,520
Reduction in the year		—		(5,821	)
Revenues from AbbVie		632		(4,301	)
Revenues from other partners		—		2,750
Total licensing and collaboration revenue	$	632	$	(1,551	)